Sports Medicine Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
Sports Medicine Unit, Catholic University of the Sacred Heart Faculty of Medicine and Surgery, Roma, Lazio, Italy.
Br J Sports Med. 2021 Jan;55(1):54-61. doi: 10.1136/bjsports-2020-102789. Epub 2020 Oct 5.
During the COVID-19 pandemic, it is essential to understand if and how to screen SARS-CoV-2-positive athletes to safely resume training and competitions. The aim of this study is to understand which investigations are useful in a screening protocol aimed at protecting health but also avoiding inappropriate examinations.
We conducted a cohort study of a professional soccer team that is based on an extensive screening protocol for resuming training during the COVID-19 pandemic. It included personal history, antigen swabs, blood tests, spirometry, resting/stress-test ECG with oxygen saturation monitoring, echocardiogram, Holter and chest CT. We also compared the findings with prior data from the same subjects before infection and with data from SARS-CoV-2-negative players.
None of the players had positive swab and/or anti-SARS-CoV-2 IgM class antibodies. Out of 30 players, 18 (60%) had IgG class antibodies. None had suffered severe SARS-CoV-2-related disease, 12 (66.7%) had complained of mild COVID-19-related symptoms and 6 (33.3%) were asymptomatic. None of the players we examined revealed significant cardiovascular abnormalities after clinical recovery. A mild reduction in spirometry parameters versus pre-COVID-19 values was observed in all athletes, but it was statistically significant (p<0.05) only in SARS-CoV-2-positive athletes. One SARS-CoV-2-positive player showed increased troponin I level, but extensive investigation did not show signs of myocardial damage.
In this small cohort of athletes with previous asymptomatic/mild SARS-CoV-2 infection, a comprehensive screening protocol including blood tests, spirometry, resting ECG, stress-test ECG with oxygen saturation monitoring and echocardiogram did not identify relevant anomalies. While larger studies are needed, extensive cardiorespiratory and haematological screening in athletes with asymptomatic/mild SARS-CoV-2 infection appears unnecessary.
在 COVID-19 大流行期间,有必要了解是否以及如何对 SARS-CoV-2 阳性运动员进行筛查,以安全地恢复训练和比赛。本研究旨在了解在旨在保护健康但又避免不适当检查的筛查方案中哪些检查是有用的。
我们对一支职业足球队进行了一项队列研究,该研究基于 COVID-19 大流行期间恢复训练的广泛筛查方案。它包括个人病史、抗原拭子、血液检查、肺功能检查、静息/应激试验心电图伴血氧饱和度监测、超声心动图、动态心电图和胸部 CT。我们还将这些发现与同一受试者感染前的先前数据以及 SARS-CoV-2 阴性运动员的数据进行了比较。
没有运动员的拭子和/或抗 SARS-CoV-2 IgM 类抗体呈阳性。在 30 名运动员中,有 18 名(60%)有 IgG 类抗体。没有运动员患有严重的 SARS-CoV-2 相关疾病,12 名(66.7%)有轻度 COVID-19 相关症状,6 名(33.3%)无症状。所有接受检查的运动员在临床康复后均未发现明显的心血管异常。所有运动员的肺功能检查参数均较 COVID-19 前值轻度降低,但仅在 SARS-CoV-2 阳性运动员中具有统计学意义(p<0.05)。一名 SARS-CoV-2 阳性运动员的肌钙蛋白 I 水平升高,但广泛检查未显示心肌损伤迹象。
在本项先前无症状/轻度 SARS-CoV-2 感染的小运动员队列中,包括血液检查、肺功能检查、静息心电图、血氧饱和度监测应激试验心电图和超声心动图在内的全面筛查方案未发现相关异常。虽然需要更大规模的研究,但对无症状/轻度 SARS-CoV-2 感染的运动员进行广泛的心肺和血液检查似乎是不必要的。